Literature DB >> 33779310

The Iodide Transport Defect-Causing Y348D Mutation in the Na+/I- Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane.

Andrea Reyna-Neyra1, Lara Jung1, Mayukh Chakrabarti2, Mikel X Suárez1, L Mario Amzel2, Nancy Carrasco1.   

Abstract

Background: The sodium/iodide (Na+/I-) symporter (NIS) mediates active transport of I- into the thyroid gland. Mutations in the SLC5A5 gene, which encodes NIS, cause I- transport defects (ITDs)-which, if left untreated, lead to congenital hypothyroidism and consequent cognitive and developmental deficiencies. The ITD-causing NIS mutation Y348D, located in transmembrane segment (TMS) 9, was reported in three Sudanese patients.
Methods: We generated cDNAs coding for Y348D NIS and mutants with other hydrophilic and hydrophobic amino acid substitutions at position 348 and transfected them into cells. The activity of the resulting mutants was quantitated by radioiodide transport assays. NIS glycosylation was investigated by Western blotting after endoglycosidase H (Endo H) and PNGase-F glycosidase treatment. Subcellular localization of the mutant proteins was ascertained by flow cytometry analysis, cell surface biotinylation, and immunofluorescence. The intrinsic activity of Y348D was studied by measuring radioiodide transport in membrane vesicles prepared from Y348D-NIS-expressing cells. Our NIS homology models and molecular dynamics simulations were used to identify residues that interact with Y348 and investigate possible interactions between Y348 and the membrane. The sequences of several Slc5 family transporters were aligned, and a phylogenetic tree was generated in ClustalX.
Results: Cells expressing Y348D NIS transport no I-. Furthermore, Y348D NIS is only partially glycosylated, is retained intracellularly, and is intrinsically inactive. Hydrophilic residues other than Asp at position 348 also yield NIS proteins that fail to be targeted to the plasma membrane (PM), whereas hydrophobic residues at this position, which we show do not interact with the membrane, rescue PM targeting and function. Conclusions: Y348D NIS does not reach the PM and is intrinsically inactive. Hydrophobic amino acid substitutions at position 348, however, preserve NIS activity. Our findings are consistent with our homology model's prediction that Y348 should face the side opposite the TMS9 residues that coordinate Na+ and participate in Na+ transport, and with the notion that Y348 interacts only with hydrophobic residues. Hydrophilic or charged residues at position 348 have deleterious effects on NIS PM targeting and activity, whereas a hydrophobic residue at this position rescues NIS activity.

Entities:  

Keywords:  Y348D NIS; intracellular retention of NIS; iodide transport defect-causing NIS mutations; molecular dynamics simulations; sodium/iodide symporter

Mesh:

Substances:

Year:  2021        PMID: 33779310      PMCID: PMC8377515          DOI: 10.1089/thy.2020.0931

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.506


  40 in total

1.  Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.

Authors:  Antonio De la Vieja; Christopher S Ginter; Nancy Carrasco
Journal:  Mol Endocrinol       Date:  2005-06-23

2.  Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity.

Authors:  Antonio De la Vieja; Mia D Reed; Christopher S Ginter; Nancy Carrasco
Journal:  J Biol Chem       Date:  2007-07-02       Impact factor: 5.157

Review 3.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

4.  A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect.

Authors:  H Fujiwara; K Tatsumi; S Tanaka; M Kimura; O Nose; N Amino
Journal:  Thyroid       Date:  2000-06       Impact factor: 6.568

5.  Mutations in SLC5A6 associated with brain, immune, bone, and intestinal dysfunction in a young child.

Authors:  Paul J Benke; Hamid M Said; Veedamali S Subramanian; Alexandru R Constantinescu
Journal:  Hum Genet       Date:  2016-11-30       Impact factor: 4.132

6.  Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types.

Authors:  Jeffery B Klauda; Richard M Venable; J Alfredo Freites; Joseph W O'Connor; Douglas J Tobias; Carlos Mondragon-Ramirez; Igor Vorobyov; Alexander D MacKerell; Richard W Pastor
Journal:  J Phys Chem B       Date:  2010-06-17       Impact factor: 2.991

7.  A Novel Missense Mutation in the SLC5A5 Gene in a Sudanese Family with Congenital Hypothyroidism.

Authors:  Yui Watanabe; Reham S Ebrhim; Mohamed A Abdullah; Roy E Weiss
Journal:  Thyroid       Date:  2018-06-05       Impact factor: 6.568

8.  Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.

Authors:  Mia D Reed-Tsur; Antonio De la Vieja; Christopher S Ginter; Nancy Carrasco
Journal:  Endocrinology       Date:  2008-03-13       Impact factor: 4.736

9.  Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients.

Authors:  S Kosugi; S Inoue; A Matsuda; S M Jhiang
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

10.  Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.

Authors:  Juan P Nicola; Nancy Carrasco; L Mario Amzel
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  3 in total

1.  Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism.

Authors:  Romina Celeste Geysels; Carlos Eduardo Bernal Barquero; Mariano Martín; Victoria Peyret; Martina Nocent; Gabriela Sobrero; Liliana Muñoz; Malvina Signorino; Graciela Testa; Ricardo Belisario Castro; Ana María Masini-Repiso; Mirta Beatriz Miras; Juan Pablo Nicola
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-04       Impact factor: 6.055

2.  A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.

Authors:  Mariano Martín; Carlos Pablo Modenutti; Mauco Lucas Gil Rosas; Victoria Peyret; Romina Celeste Geysels; Carlos Eduardo Bernal Barquero; Gabriela Sobrero; Liliana Muñoz; Malvina Signorino; Graciela Testa; Mirta Beatriz Miras; Ana María Masini-Repiso; Nora Beatriz Calcaterra; Gabriela Coux; Nancy Carrasco; Marcelo Adrián Martí; Juan Pablo Nicola
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

3.  Brief Report: A Novel Sodium/Iodide Symporter Mutation, S356F, Causing Congenital Hypothyroidism.

Authors:  Harsh Durgia; Adeline K Nicholas; Erik Schoenmakers; Jennifer A Dickens; Dhanapathi Halanaik; Jayaprakash Sahoo; Sadishkumar Kamalanathan; Nadia Schoenmakers
Journal:  Thyroid       Date:  2022-02       Impact factor: 6.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.